Elizabeth Cohen‐Jonathan‐Moyal

2.6k total citations · 1 hit paper
25 papers, 1.2k citations indexed

About

Elizabeth Cohen‐Jonathan‐Moyal is a scholar working on Molecular Biology, Genetics and Cancer Research. According to data from OpenAlex, Elizabeth Cohen‐Jonathan‐Moyal has authored 25 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 9 papers in Genetics and 9 papers in Cancer Research. Recurrent topics in Elizabeth Cohen‐Jonathan‐Moyal's work include Glioma Diagnosis and Treatment (9 papers), Cancer, Hypoxia, and Metabolism (6 papers) and Fibroblast Growth Factor Research (5 papers). Elizabeth Cohen‐Jonathan‐Moyal is often cited by papers focused on Glioma Diagnosis and Treatment (9 papers), Cancer, Hypoxia, and Metabolism (6 papers) and Fibroblast Growth Factor Research (5 papers). Elizabeth Cohen‐Jonathan‐Moyal collaborates with scholars based in France, United Kingdom and Australia. Elizabeth Cohen‐Jonathan‐Moyal's co-authors include Caroline Delmas, Christine Toulas, Michael Weller, Roger Stupp, Wolfgang Wick, Zvi Ram, Roger Henriksson, Guido Reifenberger, Riccardo Soffietti and Martin J. van den Bent and has published in prestigious journals such as Journal of Biological Chemistry, Cancer Research and Oncogene.

In The Last Decade

Elizabeth Cohen‐Jonathan‐Moyal

24 papers receiving 1.2k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

EANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastoma

2014 568 citations Michael Weller, Martin J. van den Bent et al. The Lancet Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Elizabeth Cohen‐Jonathan‐Moyal France	14	558	519	337	217	202	25	1.2k
An Claes Netherlands	13	503 0.9×	548 1.1×	275 0.8×	354 1.6×	253 1.3×	17	1.3k
Elizabeth Cohen‐Jonathan Moyal France	17	508 0.9×	328 0.6×	195 0.6×	306 1.4×	255 1.3×	50	1.1k
Soufiane El Hallani Canada	13	810 1.5×	546 1.1×	520 1.5×	276 1.3×	341 1.7×	23	1.5k
Brian Thiessen Canada	16	687 1.2×	412 0.8×	244 0.7×	220 1.0×	295 1.5×	32	1.2k
J.-C. Tonn Germany	15	724 1.3×	541 1.0×	231 0.7×	196 0.9×	318 1.6×	23	1.4k
David Tran United States	20	568 1.0×	528 1.0×	255 0.8×	485 2.2×	253 1.3×	39	1.4k
Ichiyo Shibahara Japan	19	576 1.0×	255 0.5×	181 0.5×	195 0.9×	187 0.9×	73	1.0k
Xiaoguang Qiu China	19	726 1.3×	387 0.7×	334 1.0×	165 0.8×	295 1.5×	81	1.2k
Jordonna Fulop United States	2	929 1.7×	441 0.8×	280 0.8×	213 1.0×	292 1.4×	2	1.6k
Sergey Popov United Kingdom	20	358 0.6×	825 1.6×	349 1.0×	316 1.5×	202 1.0×	48	1.5k

Countries citing papers authored by Elizabeth Cohen‐Jonathan‐Moyal

Since Specialization

Citations

This map shows the geographic impact of Elizabeth Cohen‐Jonathan‐Moyal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth Cohen‐Jonathan‐Moyal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth Cohen‐Jonathan‐Moyal more than expected).

Fields of papers citing papers by Elizabeth Cohen‐Jonathan‐Moyal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth Cohen‐Jonathan‐Moyal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth Cohen‐Jonathan‐Moyal. The network helps show where Elizabeth Cohen‐Jonathan‐Moyal may publish in the future.

Co-authorship network of co-authors of Elizabeth Cohen‐Jonathan‐Moyal

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth Cohen‐Jonathan‐Moyal. A scholar is included among the top collaborators of Elizabeth Cohen‐Jonathan‐Moyal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth Cohen‐Jonathan‐Moyal. Elizabeth Cohen‐Jonathan‐Moyal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Uro‐Coste, Emmanuelle, Yvan Nicaise, Léonor Chaltiel, et al.. (2025). Malignant Transformation in Pleomorphic Adenoma: The Impact of DNA Methylation Profiling and Pathogenic Mutations. Modern Pathology. 38(9). 100786–100786. 2 indexed citations

Nicaise, Yvan, Caroline Delmas, Elizabeth Cohen‐Jonathan‐Moyal, & Catherine Seva. (2025). PEA3 Transcription Factors, Role in Invasion, Proliferation and Radioresistance of Glioblastoma Stem Cells. Journal of Cellular and Molecular Medicine. 29(8). e70533–e70533.

Nicaise, Yvan, et al.. (2023). Overexpression of Growth Differentiation Factor 15 in Glioblastoma Stem Cells Promotes Their Radioresistance. Cancers. 16(1). 27–27. 6 indexed citations

Delmas, Caroline, et al.. (2022). The Glycoprotein M6a Is Associated with Invasiveness and Radioresistance of Glioblastoma Stem Cells. Cells. 11(14). 2128–2128. 10 indexed citations

Tensaouti, Fatima, et al.. (2022). Pseudoprogression in Glioblastoma: Role of Metabolic and Functional MRI-Systematic Review. Biomedicines. 10(2). 285–285. 24 indexed citations

Roques, Margaux, et al.. (2020). Glioblastoma survival is better analyzed on preradiotherapy MRI than on postoperative MRI residual volumes: A retrospective observational study. Clinical Neurology and Neurosurgery. 196. 105972–105972. 3 indexed citations

Roques, Margaux, et al.. (2019). Impact on survival of early tumor growth between surgery and radiotherapy in patients with de novo glioblastoma. Journal of Neuro-Oncology. 142(3). 489–497. 18 indexed citations

Kowalski‐Chauvel, Aline, A. Modesto, Valérie Gouazé‐Andersson, et al.. (2018). Alpha-6 integrin promotes radioresistance of glioblastoma by modulating DNA damage response and the transcription factor Zeb1. Cell Death and Disease. 9(9). 872–872. 33 indexed citations

Khalifa, Jonathan, et al.. (2018). Molecular PET imaging in adaptive radiotherapy: brain. The Quarterly Journal of Nuclear Medicine and Molecular Imaging. 62(4). 337–348. 5 indexed citations

10.

Kowalski‐Chauvel, Aline, Valérie Gouazé‐Andersson, Caroline Delmas, et al.. (2017). Targeting progastrin enhances radiosensitization of colorectal cancer cells. Oncotarget. 8(35). 58587–58600. 7 indexed citations

11.

Kowalski‐Chauvel, Aline, et al.. (2017). By modulating α2β1 integrin signalling, gastrin increases adhesion oF AGS-GR gastric cancer cells. Experimental Cell Research. 362(2). 498–503. 1 indexed citations

12.

Gouazé‐Andersson, Valérie, Caroline Delmas, Marion Taurand, et al.. (2016). FGFR1 Induces Glioblastoma Radioresistance through the PLCγ/Hif1α Pathway. Cancer Research. 76(10). 3036–3044. 44 indexed citations

13.

Weller, Michael, Martin J. van den Bent, Kirsten Hopkins, et al.. (2014). EANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastoma. The Lancet Oncology. 15(9). e395–e403. 568 indexed citations breakdown →

14.

Ader, Isabelle, Caroline Delmas, Nicolas Skuli, et al.. (2014). Preclinical evidence that SSR128129E – A novel small-molecule multi-fibroblast growth factor receptor blocker – Radiosensitises human glioblastoma. European Journal of Cancer. 50(13). 2351–2359. 21 indexed citations

15.

Do, Catherine, et al.. (2013). Activation of pro-oncogenic pathways in colorectal hyperplastic polyps. BMC Cancer. 13(1). 531–531. 2 indexed citations

16.

Lanvin, Olivia, Sylvie Monferran, Caroline Delmas, et al.. (2013). Radiation-induced mitotic cell death and glioblastoma radioresistance: A new regulating pathway controlled by integrin-linked kinase, hypoxia-inducible factor 1alpha and survivin in U87 cells. European Journal of Cancer. 49(13). 2884–2891. 34 indexed citations

17.

Do, Catherine, Marie‐Bernadette Delisle, Arthur Shulkes, et al.. (2012). A New Biomarker That Predicts Colonic Neoplasia Outcome in Patients with Hyperplastic Colonic Polyps. Cancer Prevention Research. 5(4). 675–684. 20 indexed citations

18.

Massabeau, Carole, Brigitte Sigal‐Zafrani, Lisa Belin, et al.. (2012). The fibroblast growth factor receptor 1 (FGFR1), a marker of response to chemoradiotherapy in breast cancer?. Breast Cancer Research and Treatment. 134(1). 259–266. 10 indexed citations

19.

Kowalski‐Chauvel, Aline, Souad Najib, Irina G. Tikhonova, et al.. (2012). Identification of the F1-ATPase at the Cell Surface of Colonic Epithelial Cells. Journal of Biological Chemistry. 287(49). 41458–41468. 13 indexed citations

20.

Skuli, Nicolas, Sylvie Monferran, Caroline Delmas, et al.. (2006). Activation of RhoB by Hypoxia Controls Hypoxia-Inducible Factor-1α Stabilization through Glycogen Synthase Kinase-3 in U87 Glioblastoma Cells. Cancer Research. 66(1). 482–489. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact